Skip to main content
Erschienen in:

02.05.2023 | Meta- Analysis

Geographic variation in the association between Hashimoto’s thyroiditis and Papillary thyroid carcinoma, a meta-analysis

verfasst von: Nabil W. G. Sweis, Ayman A. Zayed, Mira Al Jaberi, Lina AlQirem, Tala Basheer Hyasat, Farah A. Khraisat, Ward Maaita, Ahmad Moayad Naser, Abdullah Nimer, Mamoon Qatamin, Jaleel J. G. Sweis, Nadia Sweis, Abdallah T. Al-Ani, Ahmad M. Alghrabli, Alireza Haghighi

Erschienen in: Endocrine | Ausgabe 3/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The association between papillary thyroid cancer (PTC) and Hashimoto’s thyroiditis (HT) remains a matter of debate. Several genetic and environmental factors have been found to influence this association. Because of the variation in these factors among different populations, we conducted a country- and region-based meta-analysis to examine whether the geographic area influences this association.

Methods

We searched PubMed and Web of Science databases for original articles that investigated the association between HT and PTC from February 1955 to February 28, 2023. The included studies were stratified according to their country and region of origin. Various subgroup analyses were conducted. The primary outcome was the pooled relative risk (RR) and its 95% confidence interval (CI) for each region and country.

Results

Forty-six studies including a total of 93,970 participants met our inclusion criteria. They originated from 16 countries distributed in five regions. Significant variation was found among countries but not among regions. Upon analysis of all 46 included studies, countries were classified based on their RR and its 95% CI. Excluding countries with pooled sample sizes <500, Sri Lanka (RR 4.23, 95% CI 2.91–6.14), Poland (RR 3.16, 95% CI 2.79–3.57) and Japan (2.68, 2.14–3.36) showed the strongest association between HT and PTC while Greece (RR 1.06, 95% CI 1.00–1.13), Spain (RR 0.70, 95% CI 0.23–2.11), and Jordan (0.62, 0.32–1.32) showed no significant association.

Conclusion

Our findings revealed a variation in the association between HT and PTC among countries but not among regions. The country-to-country variation could be due to certain genetic and/or environmental factors subject to geographic variation that influence this association. These findings may help guide health policies aiming to mitigate the risk of PTC in the HT population by helping identify high-risk and low-risk countries.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat A. Miranda-Filho, J. Lortet-Tieulent, F. Bray, B. Cao, S. Franceschi, S. Vaccarella et al. Thyroid cancer incidence trends by histology in 25 countries: a population-based study. Lancet Diabetes Endocrinol. 9(4), 225–234 (2021)PubMedCrossRef A. Miranda-Filho, J. Lortet-Tieulent, F. Bray, B. Cao, S. Franceschi, S. Vaccarella et al. Thyroid cancer incidence trends by histology in 25 countries: a population-based study. Lancet Diabetes Endocrinol. 9(4), 225–234 (2021)PubMedCrossRef
2.
Zurück zum Zitat M.E. Dailey, S. Lindsay, R. Skahen, Relation of thyroid neoplasms to hashimoto disease of the thyroid gland. AMA Arch. Surg. 70(2), 291–297 (1955)PubMedCrossRef M.E. Dailey, S. Lindsay, R. Skahen, Relation of thyroid neoplasms to hashimoto disease of the thyroid gland. AMA Arch. Surg. 70(2), 291–297 (1955)PubMedCrossRef
3.
Zurück zum Zitat O. Büyükaşik, A.O. Hasdemir, E. Yalci̧n, B. Celep, S. Sȩngül, K. Yandakci̧ et al. The association between thyroid malignancy and chronic lymphocytic thyroiditis: Should it alter the surgical approach? Endokrynol. Pol. 62(4), 303–308 (2011)PubMed O. Büyükaşik, A.O. Hasdemir, E. Yalci̧n, B. Celep, S. Sȩngül, K. Yandakci̧ et al. The association between thyroid malignancy and chronic lymphocytic thyroiditis: Should it alter the surgical approach? Endokrynol. Pol. 62(4), 303–308 (2011)PubMed
4.
Zurück zum Zitat A.A. Zayed, M.K. Ali, O.I. Jaber, M.J. Suleiman, A.A. Ashhab, W.M. Al Shweiat et al. Is Hashimoto’s thyroiditis a risk factor for medullary thyroid carcinoma? Our experience and a literature review. Endocrine 48(2), 629–636 (2015)PubMedCrossRef A.A. Zayed, M.K. Ali, O.I. Jaber, M.J. Suleiman, A.A. Ashhab, W.M. Al Shweiat et al. Is Hashimoto’s thyroiditis a risk factor for medullary thyroid carcinoma? Our experience and a literature review. Endocrine 48(2), 629–636 (2015)PubMedCrossRef
5.
Zurück zum Zitat N. Slijepcevic, V. Zivaljevic, J. Marinkovic, S. Sipetic, A. Diklic, I. Paunovic, Retrospective evaluation of the incidental finding of 403 papillary thyroid microcarcinomas in 2466 patients undergoing thyroid surgery for presumed benign thyroid disease. BMC Cancer 15(1), 330 (2015)PubMedPubMedCentralCrossRef N. Slijepcevic, V. Zivaljevic, J. Marinkovic, S. Sipetic, A. Diklic, I. Paunovic, Retrospective evaluation of the incidental finding of 403 papillary thyroid microcarcinomas in 2466 patients undergoing thyroid surgery for presumed benign thyroid disease. BMC Cancer 15(1), 330 (2015)PubMedPubMedCentralCrossRef
6.
Zurück zum Zitat A. Konturek, M. Barczyński, W. Wierzchowski, M. Stopa, W. Nowak, Coexistence of papillary thyroid cancer with Hashimoto thyroiditis. Langenbecks Arch. Surg. 398(3), 389–394 (2013)PubMedCrossRef A. Konturek, M. Barczyński, W. Wierzchowski, M. Stopa, W. Nowak, Coexistence of papillary thyroid cancer with Hashimoto thyroiditis. Langenbecks Arch. Surg. 398(3), 389–394 (2013)PubMedCrossRef
7.
Zurück zum Zitat A. Konturek, M. Barczyński, W. Nowak, W. Wierzchowski, Risk of lymph node metastases in multifocal papillary thyroid cancer associated with Hashimoto’s thyroiditis. Langenbecks Arch. Surg. 399(2), 229–236 (2014)PubMedPubMedCentralCrossRef A. Konturek, M. Barczyński, W. Nowak, W. Wierzchowski, Risk of lymph node metastases in multifocal papillary thyroid cancer associated with Hashimoto’s thyroiditis. Langenbecks Arch. Surg. 399(2), 229–236 (2014)PubMedPubMedCentralCrossRef
8.
Zurück zum Zitat C. Cipolla, L. Sandonato, G. Graceffa, S. Fricano, A. Torcivia, S. Vieni et al. Hashimoto thyroiditis coexistent with papillary thyroid carcinoma. Am. Surg. 71(10), 874–878 (2005)PubMedCrossRef C. Cipolla, L. Sandonato, G. Graceffa, S. Fricano, A. Torcivia, S. Vieni et al. Hashimoto thyroiditis coexistent with papillary thyroid carcinoma. Am. Surg. 71(10), 874–878 (2005)PubMedCrossRef
9.
Zurück zum Zitat J. Kim, J.E. Gosnell, S.A. Roman, Geographic influences in the global rise of thyroid cancer. Nat. Rev. Endocrinol. 16, 17–29 (2020)PubMedCrossRef J. Kim, J.E. Gosnell, S.A. Roman, Geographic influences in the global rise of thyroid cancer. Nat. Rev. Endocrinol. 16, 17–29 (2020)PubMedCrossRef
10.
Zurück zum Zitat D.S.A. McLeod, D.S. Cooper, The incidence and prevalence of thyroid autoimmunity. Endocrine 42, 252–265 (2012)PubMedCrossRef D.S.A. McLeod, D.S. Cooper, The incidence and prevalence of thyroid autoimmunity. Endocrine 42, 252–265 (2012)PubMedCrossRef
11.
Zurück zum Zitat Y. Tomer, T.F. Davies, Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function. Endocr. Rev. 24, 694–717 (2003)PubMedCrossRef Y. Tomer, T.F. Davies, Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function. Endocr. Rev. 24, 694–717 (2003)PubMedCrossRef
12.
Zurück zum Zitat E.M. Kyritsi, C. Kanaka-Gantenbein, Autoimmune thyroid disease in specific genetic syndromes in childhood and adolescence. Front. Endocrinol. 11, 543 (2020)CrossRef E.M. Kyritsi, C. Kanaka-Gantenbein, Autoimmune thyroid disease in specific genetic syndromes in childhood and adolescence. Front. Endocrinol. 11, 543 (2020)CrossRef
13.
Zurück zum Zitat Q. Wu, M.P. Rayman, H. Lv, L. Schomburg, B. Cui, C. Gao et al. Low population selenium status is associated with increased prevalence of thyroid disease. J. Clin. Endocrinol. Metab. 100(11), 4037–4047 (2015)PubMedCrossRef Q. Wu, M.P. Rayman, H. Lv, L. Schomburg, B. Cui, C. Gao et al. Low population selenium status is associated with increased prevalence of thyroid disease. J. Clin. Endocrinol. Metab. 100(11), 4037–4047 (2015)PubMedCrossRef
14.
Zurück zum Zitat B.O. Åsvold, T. Bjøro, T.I.L. Nilsen, L.J. Vatten, Tobacco smoking and thyroid function: a population-based study. Arch. Intern Med. 167(13), 1428–1432 (2007)PubMedCrossRef B.O. Åsvold, T. Bjøro, T.I.L. Nilsen, L.J. Vatten, Tobacco smoking and thyroid function: a population-based study. Arch. Intern Med. 167(13), 1428–1432 (2007)PubMedCrossRef
15.
Zurück zum Zitat S.P. Cheng, P.H. Yin, Y.C. Hsu, Y.C. Chang, S.Y. Huang, J.J. Lee et al. Leptin enhances migration of human papillary thyroid cancer cells through the PI3K/AKT and MEK/ERK signaling pathways. Oncol. Rep. 26(5), 1265–1271 (2011)PubMed S.P. Cheng, P.H. Yin, Y.C. Hsu, Y.C. Chang, S.Y. Huang, J.J. Lee et al. Leptin enhances migration of human papillary thyroid cancer cells through the PI3K/AKT and MEK/ERK signaling pathways. Oncol. Rep. 26(5), 1265–1271 (2011)PubMed
16.
Zurück zum Zitat C. Wang, Z. Wang, W. Liu, Z. Ai, ROS-generating oxidase NOX1 promotes the self-renewal activity of CD133+ thyroid cancer cells through activation of the Akt signaling. Cancer Lett. 447, 154–163 (2019)PubMedCrossRef C. Wang, Z. Wang, W. Liu, Z. Ai, ROS-generating oxidase NOX1 promotes the self-renewal activity of CD133+ thyroid cancer cells through activation of the Akt signaling. Cancer Lett. 447, 154–163 (2019)PubMedCrossRef
17.
Zurück zum Zitat T. Pappa, M. Alevizaki, Obesity and thyroid cancer: a clinical update. Thyroid 24, 190–199 (2014)PubMedCrossRef T. Pappa, M. Alevizaki, Obesity and thyroid cancer: a clinical update. Thyroid 24, 190–199 (2014)PubMedCrossRef
18.
Zurück zum Zitat J. Liu, T. Xu, L. Ma, W. Chang, Signal pathway of estrogen and estrogen receptor in the development of thyroid cancer. Front. Oncol. 11, 593479 (2021)PubMedPubMedCentralCrossRef J. Liu, T. Xu, L. Ma, W. Chang, Signal pathway of estrogen and estrogen receptor in the development of thyroid cancer. Front. Oncol. 11, 593479 (2021)PubMedPubMedCentralCrossRef
19.
Zurück zum Zitat Z. Cheng, S. Yu, W. He, J. Li, T. Xu, J. Xue et al. Selenite induces cell cycle arrest and apoptosis via reactive oxygen species-dependent inhibition of the AKT/mTOR pathway in thyroid cancer. Front Oncol. 11, 668424 (2021)PubMedPubMedCentralCrossRef Z. Cheng, S. Yu, W. He, J. Li, T. Xu, J. Xue et al. Selenite induces cell cycle arrest and apoptosis via reactive oxygen species-dependent inhibition of the AKT/mTOR pathway in thyroid cancer. Front Oncol. 11, 668424 (2021)PubMedPubMedCentralCrossRef
20.
Zurück zum Zitat K. Suzuki, H. Yamada, A. Nagura, K. Ohashi, H. Ishikawa, M. Yamazaki et al. Association of cigarette smoking with serum microRNA expression among middle-aged Japanese adults. Fujita Med. J. 2(1), 1–5 (2016) K. Suzuki, H. Yamada, A. Nagura, K. Ohashi, H. Ishikawa, M. Yamazaki et al. Association of cigarette smoking with serum microRNA expression among middle-aged Japanese adults. Fujita Med. J. 2(1), 1–5 (2016)
21.
Zurück zum Zitat N. Li, X. Liu, L. Han, R. Zhou, J. Yan, G. Zhao et al. Expression of miRNA-146b-5p in patients with thyroid cancer in combination with Hashimoto’s disease and its clinical significance. Oncol. Lett. 17(6), 4871–4876 (2019)PubMedPubMedCentral N. Li, X. Liu, L. Han, R. Zhou, J. Yan, G. Zhao et al. Expression of miRNA-146b-5p in patients with thyroid cancer in combination with Hashimoto’s disease and its clinical significance. Oncol. Lett. 17(6), 4871–4876 (2019)PubMedPubMedCentral
22.
Zurück zum Zitat M.J. Page, J.E. McKenzie, P.M. Bossuyt, I. Boutron, T.C. Hoffmann, C.D. Mulrow et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372, 105906–189 (2021) M.J. Page, J.E. McKenzie, P.M. Bossuyt, I. Boutron, T.C. Hoffmann, C.D. Mulrow et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372, 105906–189 (2021)
23.
Zurück zum Zitat B.J. Shea, B.C. Reeves, G. Wells, M. Thuku, C. Hamel, J. Moran et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ (Online) 358, j4008 (2017)PubMed B.J. Shea, B.C. Reeves, G. Wells, M. Thuku, C. Hamel, J. Moran et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ (Online) 358, j4008 (2017)PubMed
24.
Zurück zum Zitat I. Okayasu, M. Fujiwara, Y. Hara, Y. Tanaka, N.R. Rose, Association of chronic lymphocytic thyroiditis and thyroid papillary carcinoma. A study of surgical cases among Japanese, and white and African Americans. Cancer 76(11), 2312–2318 (1995)PubMedCrossRef I. Okayasu, M. Fujiwara, Y. Hara, Y. Tanaka, N.R. Rose, Association of chronic lymphocytic thyroiditis and thyroid papillary carcinoma. A study of surgical cases among Japanese, and white and African Americans. Cancer 76(11), 2312–2318 (1995)PubMedCrossRef
25.
Zurück zum Zitat M.K. McLeod, M.E. East, R.E. Burney, J.K. Harness, N.W. Thompson, Hashimoto’s thyroiditis revisited: the association with thyroid cancer remains obscure. World J. Surg. 12(4), 509–515 (1988)PubMedCrossRef M.K. McLeod, M.E. East, R.E. Burney, J.K. Harness, N.W. Thompson, Hashimoto’s thyroiditis revisited: the association with thyroid cancer remains obscure. World J. Surg. 12(4), 509–515 (1988)PubMedCrossRef
26.
Zurück zum Zitat C.A. Peterson, F.P. Shidler, Lymphocytic thyroiditis in 757 thyroid operations. Am. J. Surg. 94(2), 223–228 (1957)PubMedCrossRef C.A. Peterson, F.P. Shidler, Lymphocytic thyroiditis in 757 thyroid operations. Am. J. Surg. 94(2), 223–228 (1957)PubMedCrossRef
27.
28.
Zurück zum Zitat V.E. Chesky, C.A. Hellwig, J.W. Welch, Cancer of the thyroid asociated with Hashimoto’s disease: an analysis of forty-eight cases. Am. Surg. 28, 678–685 (1962)PubMed V.E. Chesky, C.A. Hellwig, J.W. Welch, Cancer of the thyroid asociated with Hashimoto’s disease: an analysis of forty-eight cases. Am. Surg. 28, 678–685 (1962)PubMed
29.
Zurück zum Zitat S.D. Larson, L.N. Jackson, T.S. Riall, T. Uchida, R.P. Thomas, S. Qiu et al. Increased incidence of well-differentiated thyroid cancer associated with hashimoto thyroiditis and the role of the PI3k/Akt pathway. J. Am. Coll. Surg. 204(5), 764–773 (2007)PubMedPubMedCentralCrossRef S.D. Larson, L.N. Jackson, T.S. Riall, T. Uchida, R.P. Thomas, S. Qiu et al. Increased incidence of well-differentiated thyroid cancer associated with hashimoto thyroiditis and the role of the PI3k/Akt pathway. J. Am. Coll. Surg. 204(5), 764–773 (2007)PubMedPubMedCentralCrossRef
30.
Zurück zum Zitat D. Repplinger, A. Bargren, Y.W. Zhang, J.T. Adler, M. Haymart, H. Chen, Is Hashimoto’s thyroiditis a risk factor for Papillary thyroid cancer? J. Surgical Res. 150(1), 49–52 (2008)CrossRef D. Repplinger, A. Bargren, Y.W. Zhang, J.T. Adler, M. Haymart, H. Chen, Is Hashimoto’s thyroiditis a risk factor for Papillary thyroid cancer? J. Surgical Res. 150(1), 49–52 (2008)CrossRef
31.
Zurück zum Zitat D.P. Bradly, V. Reddy, R.A. Prinz, P. Gattuso, Incidental papillary carcinoma in patients treated surgically for benign thyroid diseases. Surgery 146(6), 1099–1104 (2009)PubMedCrossRef D.P. Bradly, V. Reddy, R.A. Prinz, P. Gattuso, Incidental papillary carcinoma in patients treated surgically for benign thyroid diseases. Surgery 146(6), 1099–1104 (2009)PubMedCrossRef
32.
Zurück zum Zitat R. Paparodis, S. Imam, K. Todorova-Koteva, A. Staii, J.C. Jaume, Hashimoto’s thyroiditis pathology and risk for thyroid cancer. Thyroid 24(7), 1107–1114 (2014)PubMedPubMedCentralCrossRef R. Paparodis, S. Imam, K. Todorova-Koteva, A. Staii, J.C. Jaume, Hashimoto’s thyroiditis pathology and risk for thyroid cancer. Thyroid 24(7), 1107–1114 (2014)PubMedPubMedCentralCrossRef
33.
Zurück zum Zitat D. Jackson, R.S. Handelsman, J.C. Farrá, J.I. Lew, Increased incidental thyroid cancer in patients with subclinical chronic lymphocytic thyroiditis. J. Surgical Res. 245, 115–118 (2020)CrossRef D. Jackson, R.S. Handelsman, J.C. Farrá, J.I. Lew, Increased incidental thyroid cancer in patients with subclinical chronic lymphocytic thyroiditis. J. Surgical Res. 245, 115–118 (2020)CrossRef
34.
Zurück zum Zitat L.A.A.F. Campos, S.M. Picado, A.V. Guimarães, D.A. Ribeiro, R.A. Dedivitis, Thyroid papillary carcinoma associated to hashimoto’s thyroiditis. Braz. J. Otorhinolaryngol. 78(6), 77–80 (2012)PubMedCrossRef L.A.A.F. Campos, S.M. Picado, A.V. Guimarães, D.A. Ribeiro, R.A. Dedivitis, Thyroid papillary carcinoma associated to hashimoto’s thyroiditis. Braz. J. Otorhinolaryngol. 78(6), 77–80 (2012)PubMedCrossRef
35.
Zurück zum Zitat D.M. de Alcântara-Jones, T.F. de Alcântara-Nunes, O. Rocha Bde, R.D. de Oliveira, A.C. Santana, F.T. de Alcântara et al. Is there any association between Hashimoto’s thyroiditis and thyroid cancer? A retrospective data analysis. Radio. Bras. 48(3), 148–153 (2015)CrossRef D.M. de Alcântara-Jones, T.F. de Alcântara-Nunes, O. Rocha Bde, R.D. de Oliveira, A.C. Santana, F.T. de Alcântara et al. Is there any association between Hashimoto’s thyroiditis and thyroid cancer? A retrospective data analysis. Radio. Bras. 48(3), 148–153 (2015)CrossRef
36.
Zurück zum Zitat O. Kurukahvecioglu, F. Taneri, O. Yüksel, A. Aydin, E. Tezel, E. Onuk, Total thyroidectomy for the treatment of Hashimoto’s thyroiditis coexisting with papillary thyroid carcinoma. Adv. Ther. 24(3), 510–516 (2007)PubMedCrossRef O. Kurukahvecioglu, F. Taneri, O. Yüksel, A. Aydin, E. Tezel, E. Onuk, Total thyroidectomy for the treatment of Hashimoto’s thyroiditis coexisting with papillary thyroid carcinoma. Adv. Ther. 24(3), 510–516 (2007)PubMedCrossRef
37.
Zurück zum Zitat K. Gul, A. Dirikoc, G. Kiyak, P.E. Ersoy, N.S. Ugras, R. Ersoy et al. The association between thyroid carcinoma and Hashimoto’s thyroiditis: the ultrasonographic and histopathologic characteristics of malignant nodules. Thyroid 20(8), 873–878 (2010)PubMedCrossRef K. Gul, A. Dirikoc, G. Kiyak, P.E. Ersoy, N.S. Ugras, R. Ersoy et al. The association between thyroid carcinoma and Hashimoto’s thyroiditis: the ultrasonographic and histopathologic characteristics of malignant nodules. Thyroid 20(8), 873–878 (2010)PubMedCrossRef
38.
Zurück zum Zitat N. Danis, A. Comlekci, S. Yener, M. Durak, M. Calan, D. Solmaz et al. Association between Hashimoto’s thyroiditis and papillary thyroid cancer: a single center experience. Acta Endocrinologica (Buchar.) 18(1), 74–78 (2022)CrossRef N. Danis, A. Comlekci, S. Yener, M. Durak, M. Calan, D. Solmaz et al. Association between Hashimoto’s thyroiditis and papillary thyroid cancer: a single center experience. Acta Endocrinologica (Buchar.) 18(1), 74–78 (2022)CrossRef
39.
Zurück zum Zitat Z. Çetin, Ö. Başer, S. Güler, Hashimoto’s thyroiditis is not a negative contributor to papillary thyroid cancer. Eur. J. Ther. 28(1), 30–36 (2022)CrossRef Z. Çetin, Ö. Başer, S. Güler, Hashimoto’s thyroiditis is not a negative contributor to papillary thyroid cancer. Eur. J. Ther. 28(1), 30–36 (2022)CrossRef
40.
Zurück zum Zitat E. Fiore, T. Rago, M. Scutari, C. Ugolini, A. Proietti, G. Di Coscio et al. Papillary thyroid cancer, although strongly associated with lymphocitic infiltration on histology, is only weakly predicted by serum thyroid auto-antibodies in patients with nodular thyroid diseases. J. Endocrinol. Invest 32(4), 344–351 (2009)PubMedCrossRef E. Fiore, T. Rago, M. Scutari, C. Ugolini, A. Proietti, G. Di Coscio et al. Papillary thyroid cancer, although strongly associated with lymphocitic infiltration on histology, is only weakly predicted by serum thyroid auto-antibodies in patients with nodular thyroid diseases. J. Endocrinol. Invest 32(4), 344–351 (2009)PubMedCrossRef
41.
Zurück zum Zitat F. Cappellacci, G.L. Canu, M.L. Lai, E. Lori, M. Biancu, F. Boi et al. Association between hashimoto thyroiditis and differentiated thyroid cancer: a single-center experience. Front Oncol. 12, 959595 (2022)PubMedPubMedCentralCrossRef F. Cappellacci, G.L. Canu, M.L. Lai, E. Lori, M. Biancu, F. Boi et al. Association between hashimoto thyroiditis and differentiated thyroid cancer: a single-center experience. Front Oncol. 12, 959595 (2022)PubMedPubMedCentralCrossRef
42.
Zurück zum Zitat E.E. Mazokopakis, A.A. Tzortzinis, E.I. Dalieraki-Ott, A.N. Tsartsalis, P.K. Syros, C.M. Karefilakis et al. Coexistence of Hashimoto’s thyroiditis with papillary thyroid carcinoma. a retrospective study. Hormones 9(4), 312–317 (2010)PubMedCrossRef E.E. Mazokopakis, A.A. Tzortzinis, E.I. Dalieraki-Ott, A.N. Tsartsalis, P.K. Syros, C.M. Karefilakis et al. Coexistence of Hashimoto’s thyroiditis with papillary thyroid carcinoma. a retrospective study. Hormones 9(4), 312–317 (2010)PubMedCrossRef
43.
Zurück zum Zitat I. Giagourta, C. Evangelopoulou, G. Papaioannou, G. Kassi, E. Zapanti, M. Prokopiou et al. Autoimmune thyroiditis in benign and malignant thyroid nodules: 16-year results. Head. Neck 36(4), 531–535 (2014)PubMedCrossRef I. Giagourta, C. Evangelopoulou, G. Papaioannou, G. Kassi, E. Zapanti, M. Prokopiou et al. Autoimmune thyroiditis in benign and malignant thyroid nodules: 16-year results. Head. Neck 36(4), 531–535 (2014)PubMedCrossRef
44.
Zurück zum Zitat G.N. Kassi, C.C. Evangelopoulou, K.D. Papapostolou, H.J. Karga, Benign and malignant thyroid nodules with autoimmune thyroiditis. Arch. Endocrinol. Metab. 66, 446–451 (2022)PubMed G.N. Kassi, C.C. Evangelopoulou, K.D. Papapostolou, H.J. Karga, Benign and malignant thyroid nodules with autoimmune thyroiditis. Arch. Endocrinol. Metab. 66, 446–451 (2022)PubMed
45.
Zurück zum Zitat J. de Carlos, A. Ernaga, A. Irigaray, J.J. Pineda, A. Echegoyen, P. Salvador et al. Incidentally discovered papillary thyroid microcarcinoma in patients undergoing thyroid surgery for benign disease. Endocrine 77(2), 325–332 (2022)PubMedCrossRef J. de Carlos, A. Ernaga, A. Irigaray, J.J. Pineda, A. Echegoyen, P. Salvador et al. Incidentally discovered papillary thyroid microcarcinoma in patients undergoing thyroid surgery for benign disease. Endocrine 77(2), 325–332 (2022)PubMedCrossRef
46.
Zurück zum Zitat J.L. Codaccioni, R. Jean, R. Depieds, P. Jaquet, C. Pianeta, G. Lebreuil. Clinical, histopathological and biological data for thyroiditis diagnosis. In: Annales d’endocrinologie. [Clinical, histopathological and biological data for thyroiditis diagnosis], Annales d'endocrinologie, 1972, p. 404–416 J.L. Codaccioni, R. Jean, R. Depieds, P. Jaquet, C. Pianeta, G. Lebreuil. Clinical, histopathological and biological data for thyroiditis diagnosis. In: Annales d’endocrinologie. [Clinical, histopathological and biological data for thyroiditis diagnosis], Annales d'endocrinologie, 1972, p. 404–416
47.
Zurück zum Zitat E.H. Siriweera, N.V.I. Ratnatunga, Profile of Hashimoto’s thyroiditis in Sri Lankans: is there an increased risk of ancillary pathologies in Hashimoto’s thyroiditis? J. Thyroid Res. 2010, 2010–2015 (2010)CrossRef E.H. Siriweera, N.V.I. Ratnatunga, Profile of Hashimoto’s thyroiditis in Sri Lankans: is there an increased risk of ancillary pathologies in Hashimoto’s thyroiditis? J. Thyroid Res. 2010, 2010–2015 (2010)CrossRef
48.
Zurück zum Zitat D. Ghartimagar, A. Ghosh, M.K. Shrestha, S. Thapa, O.P. Talwar, Histopathological spectrum of non-neoplastic and neoplastic lesions of thyroid: a descriptive cross-sectional study. Journal of Nepal Medical Association. JNMA; J. Nepal Med. Assoc. 58(231), 856–861 (2020)PubMedPubMedCentral D. Ghartimagar, A. Ghosh, M.K. Shrestha, S. Thapa, O.P. Talwar, Histopathological spectrum of non-neoplastic and neoplastic lesions of thyroid: a descriptive cross-sectional study. Journal of Nepal Medical Association. JNMA; J. Nepal Med. Assoc. 58(231), 856–861 (2020)PubMedPubMedCentral
49.
Zurück zum Zitat G. Gejoe, I.P. Yadev, A. Kumaran, K.S. Swasthik, M.M. Chisthi, Coexistence of histologically proven chronic lymphocytic thyroiditis with other thyroid disorders: a retrospective study. Surg. J. 8(02), e131–e135 (2022)CrossRef G. Gejoe, I.P. Yadev, A. Kumaran, K.S. Swasthik, M.M. Chisthi, Coexistence of histologically proven chronic lymphocytic thyroiditis with other thyroid disorders: a retrospective study. Surg. J. 8(02), e131–e135 (2022)CrossRef
50.
Zurück zum Zitat D. Ahn, S.J. Heo, J.H. Park, J.H. Kim, J.H. Sohn, J.Y. Park et al. Clinical relationship between Hashimoto’s thyroiditis and papillary thyroid cancer. Acta Oncol. (Madr.) 50(8), 1228–1234 (2011)CrossRef D. Ahn, S.J. Heo, J.H. Park, J.H. Kim, J.H. Sohn, J.Y. Park et al. Clinical relationship between Hashimoto’s thyroiditis and papillary thyroid cancer. Acta Oncol. (Madr.) 50(8), 1228–1234 (2011)CrossRef
51.
Zurück zum Zitat K.W. Kim, Y.J. Park, E.H. Kim, S.Y. Park, D.J. Park, S.H. Ahn et al. Elevated risk of papillary thyroid cancer in Korean patients with Hashimoto’s thyroiditis. Head. Neck 33(5), 691–695 (2011)PubMedCrossRef K.W. Kim, Y.J. Park, E.H. Kim, S.Y. Park, D.J. Park, S.H. Ahn et al. Elevated risk of papillary thyroid cancer in Korean patients with Hashimoto’s thyroiditis. Head. Neck 33(5), 691–695 (2011)PubMedCrossRef
52.
Zurück zum Zitat L. Zhang, H. Li, Q.H. Ji, Y.X. Zhu, Z.Y. Wang, Y. Wang et al. The clinical features of papillary thyroid cancer in Hashimoto’s thyroiditis patients from an area with a high prevalence of Hashimoto’s disease. BMC Cancer 12, 12 (2012)CrossRef L. Zhang, H. Li, Q.H. Ji, Y.X. Zhu, Z.Y. Wang, Y. Wang et al. The clinical features of papillary thyroid cancer in Hashimoto’s thyroiditis patients from an area with a high prevalence of Hashimoto’s disease. BMC Cancer 12, 12 (2012)CrossRef
53.
Zurück zum Zitat Z.Q. Ye, D.N. Gu, H.Y. Hu, Y.L. Zhou, X.Q. Hu, X.H. Zhang, Hashimoto’s Thyroiditis, microcalcification and raised thyrotropin levels within normal range are associated with thyroid cancer. World J. Surg. Oncol. 11, 56 (2013)PubMedPubMedCentralCrossRef Z.Q. Ye, D.N. Gu, H.Y. Hu, Y.L. Zhou, X.Q. Hu, X.H. Zhang, Hashimoto’s Thyroiditis, microcalcification and raised thyrotropin levels within normal range are associated with thyroid cancer. World J. Surg. Oncol. 11, 56 (2013)PubMedPubMedCentralCrossRef
54.
Zurück zum Zitat Y. Lun, X. Wu, Q. Xia, Y. Han, X. Zhang, Z. Liu et al. Hashimoto’s thyroiditis as a risk factor of papillary thyroid cancer may improve cancer prognosis. Otolaryngol. - Head. Neck Surg. (U. S.) 148(3), 396–402 (2013)CrossRef Y. Lun, X. Wu, Q. Xia, Y. Han, X. Zhang, Z. Liu et al. Hashimoto’s thyroiditis as a risk factor of papillary thyroid cancer may improve cancer prognosis. Otolaryngol. - Head. Neck Surg. (U. S.) 148(3), 396–402 (2013)CrossRef
55.
Zurück zum Zitat Y. Zhang, J. Dai, T. Wu, N. Yang, Z. Yin, The study of the coexistence of Hashimoto’s thyroiditis with papillary thyroid carcinoma. J. Cancer Res. Clin. Oncol. 140(6), 1021–1026 (2014)PubMedCrossRef Y. Zhang, J. Dai, T. Wu, N. Yang, Z. Yin, The study of the coexistence of Hashimoto’s thyroiditis with papillary thyroid carcinoma. J. Cancer Res. Clin. Oncol. 140(6), 1021–1026 (2014)PubMedCrossRef
56.
Zurück zum Zitat Y. Zhang, X.P. Ma, X.P. Ma, F.S. Deng, Z.R. Liu, H.Q. Wei et al. The effect of chronic lymphocytic thyroiditis on patients with thyroid cancer. World J. Surg. Oncol. 12(1), 277 (2014)PubMedPubMedCentralCrossRef Y. Zhang, X.P. Ma, X.P. Ma, F.S. Deng, Z.R. Liu, H.Q. Wei et al. The effect of chronic lymphocytic thyroiditis on patients with thyroid cancer. World J. Surg. Oncol. 12(1), 277 (2014)PubMedPubMedCentralCrossRef
57.
Zurück zum Zitat X. Liu, L. Zhu, D. Cui, Z. Wang, H. Chen, Y. Duan et al. Coexistence of histologically confirmed Hashimoto’s thyroiditis with different stages of papillary thyroid carcinoma in a consecutive Chinese cohort. Int J. Endocrinol. 2014, 2014–2017 (2014)CrossRef X. Liu, L. Zhu, D. Cui, Z. Wang, H. Chen, Y. Duan et al. Coexistence of histologically confirmed Hashimoto’s thyroiditis with different stages of papillary thyroid carcinoma in a consecutive Chinese cohort. Int J. Endocrinol. 2014, 2014–2017 (2014)CrossRef
58.
Zurück zum Zitat R. Zeng, T. Shou, K.X. Yang, T. Shen, J.P. Zhang, R.X. Zuo et al. Papillary thyroid carcinoma risk factors in the Yunnan plateau of southwestern China. Ther. Clin. Risk Manag 12, 1065–1074 (2016)PubMedPubMedCentralCrossRef R. Zeng, T. Shou, K.X. Yang, T. Shen, J.P. Zhang, R.X. Zuo et al. Papillary thyroid carcinoma risk factors in the Yunnan plateau of southwestern China. Ther. Clin. Risk Manag 12, 1065–1074 (2016)PubMedPubMedCentralCrossRef
59.
Zurück zum Zitat S. Dong, J. Pan, Y.B. Shen, L.X. Zhu, Q. Xia, X.J. Xie et al. Factors associated with malignancy in patients with maximal thyroid nodules ≥2 Cm. Cancer Manag Res. 13, 4473–4482 (2021)PubMedPubMedCentralCrossRef S. Dong, J. Pan, Y.B. Shen, L.X. Zhu, Q. Xia, X.J. Xie et al. Factors associated with malignancy in patients with maximal thyroid nodules ≥2 Cm. Cancer Manag Res. 13, 4473–4482 (2021)PubMedPubMedCentralCrossRef
60.
Zurück zum Zitat Z. Han, L. Xie, P. Wei, Z. Lei, Z. Ding, M. Zhang, Ultrasound gray scale ratio for differential diagnosis of papillary thyroid microcarcinoma from benign micronodule in patients with Hashimoto’s thyroiditis. BMC Endocr. Disord. 22(1), 1–10 (2022)CrossRef Z. Han, L. Xie, P. Wei, Z. Lei, Z. Ding, M. Zhang, Ultrasound gray scale ratio for differential diagnosis of papillary thyroid microcarcinoma from benign micronodule in patients with Hashimoto’s thyroiditis. BMC Endocr. Disord. 22(1), 1–10 (2022)CrossRef
61.
Zurück zum Zitat L. Mao, C. Zheng, S. Ou, Y. He, C. Liao, G. Deng, Influence of Hashimoto thyroiditis on diagnosis and treatment of thyroid nodules. Front Endocrinol. (Lausanne) 13, 1067390 (2022)PubMedCrossRef L. Mao, C. Zheng, S. Ou, Y. He, C. Liao, G. Deng, Influence of Hashimoto thyroiditis on diagnosis and treatment of thyroid nodules. Front Endocrinol. (Lausanne) 13, 1067390 (2022)PubMedCrossRef
62.
Zurück zum Zitat P. Abbasgholizadeh, A. Naseri, E. Nasiri, V. Sadra, Is Hashimoto thyroiditis associated with increasing risk of thyroid malignancies? A systematic review and meta-analysis. Thyroid Res. 14, 26 (2021)PubMedPubMedCentralCrossRef P. Abbasgholizadeh, A. Naseri, E. Nasiri, V. Sadra, Is Hashimoto thyroiditis associated with increasing risk of thyroid malignancies? A systematic review and meta-analysis. Thyroid Res. 14, 26 (2021)PubMedPubMedCentralCrossRef
63.
Zurück zum Zitat X. Hu, X. Wang, Y. Liang, X. Chen, S. Zhou, W. Fei et al. Cancer risk in Hashimoto’s thyroiditis: a systematic review and meta-analysis. Front. Endocrinol. Frontiers Media S.A. 13, 937871 (2022)CrossRef X. Hu, X. Wang, Y. Liang, X. Chen, S. Zhou, W. Fei et al. Cancer risk in Hashimoto’s thyroiditis: a systematic review and meta-analysis. Front. Endocrinol. Frontiers Media S.A. 13, 937871 (2022)CrossRef
64.
Zurück zum Zitat B. Jankovic, K.T. Le, J.M. Hershman, Hashimoto’s thyroiditis and papillary thyroid carcinoma: is there a correlation? J. Clin. Endocrinol. Metab. 98, 474–482 (2013)PubMedCrossRef B. Jankovic, K.T. Le, J.M. Hershman, Hashimoto’s thyroiditis and papillary thyroid carcinoma: is there a correlation? J. Clin. Endocrinol. Metab. 98, 474–482 (2013)PubMedCrossRef
65.
Zurück zum Zitat A. Wirtschafter, R. Schmidt, D. Rosen, N. Kundu, M. Santoro, A. Fusco et al. Expression of the RET/PTC fusion gene as a marker for papillary carcinoma in Hashimoto’s thyroiditis. Laryngoscope 107(1), 95–100 (1997)PubMedCrossRef A. Wirtschafter, R. Schmidt, D. Rosen, N. Kundu, M. Santoro, A. Fusco et al. Expression of the RET/PTC fusion gene as a marker for papillary carcinoma in Hashimoto’s thyroiditis. Laryngoscope 107(1), 95–100 (1997)PubMedCrossRef
66.
Zurück zum Zitat C.E. Anderson, C. Graham, M.M. Herriot, H.M. Kamel, D.M. Salter, CD98 expression is decreased in papillary carcinoma of the thyroid and Hashimoto’s thyroiditis. Histopathology 55(6), 683–686 (2009)PubMedCrossRef C.E. Anderson, C. Graham, M.M. Herriot, H.M. Kamel, D.M. Salter, CD98 expression is decreased in papillary carcinoma of the thyroid and Hashimoto’s thyroiditis. Histopathology 55(6), 683–686 (2009)PubMedCrossRef
67.
Zurück zum Zitat M.C. Royer, H. Zhang, C.Y. Fan, M.S. Kokoska, Genetic alterations in papillary thyroid carcinoma and hashimoto thyroiditis: an analysis of hOGG1 loss of heterozygosity. Arch. Otolaryngol. - Head. Neck Surg. 136(3), 240–242 (2010)PubMedCrossRef M.C. Royer, H. Zhang, C.Y. Fan, M.S. Kokoska, Genetic alterations in papillary thyroid carcinoma and hashimoto thyroiditis: an analysis of hOGG1 loss of heterozygosity. Arch. Otolaryngol. - Head. Neck Surg. 136(3), 240–242 (2010)PubMedCrossRef
68.
Zurück zum Zitat L. Zhang, L. Zhou, Q. Feng, Q. Li, M. Ge, Mutation of Hashimoto’s thyroiditis and papillary thyroid carcinoma related genes and the screening of candidate genes. Front. Oncol. 11(Dec), 11 (2021) L. Zhang, L. Zhou, Q. Feng, Q. Li, M. Ge, Mutation of Hashimoto’s thyroiditis and papillary thyroid carcinoma related genes and the screening of candidate genes. Front. Oncol. 11(Dec), 11 (2021)
69.
Zurück zum Zitat D.L. Morris, L. Rui, Recent advances in understanding leptin signaling and leptin resistance. Am. J. Physiol. - Endocrinol. Metab. 297, E1247–E1259 (2009)PubMedPubMedCentralCrossRef D.L. Morris, L. Rui, Recent advances in understanding leptin signaling and leptin resistance. Am. J. Physiol. - Endocrinol. Metab. 297, E1247–E1259 (2009)PubMedPubMedCentralCrossRef
70.
Zurück zum Zitat M. Obradovic, E. Sudar-Milovanovic, S. Soskic, M. Essack, S. Arya, A.J. Stewart et al. Leptin and obesity: role and clinical implication. Front. Endocrinol. 12, 585887 (2021)CrossRef M. Obradovic, E. Sudar-Milovanovic, S. Soskic, M. Essack, S. Arya, A.J. Stewart et al. Leptin and obesity: role and clinical implication. Front. Endocrinol. 12, 585887 (2021)CrossRef
71.
Zurück zum Zitat S. Uddin, P. Bavi, A.K. Siraj, M. Ahmed, M. Al-Rasheed, A.R. Hussain et al. Leptin-R and its association with PI3K/AKT signaling pathway in papillary thyroid carcinoma. Endocr. Relat. Cancer 17(1), 191–202 (2010)PubMedCrossRef S. Uddin, P. Bavi, A.K. Siraj, M. Ahmed, M. Al-Rasheed, A.R. Hussain et al. Leptin-R and its association with PI3K/AKT signaling pathway in papillary thyroid carcinoma. Endocr. Relat. Cancer 17(1), 191–202 (2010)PubMedCrossRef
72.
Zurück zum Zitat S. Brauna, K. Bitton-Worms, D. le Roith, The link between the metabolic syndrome and cancer. Int. J. Biol. Sci. 7, 1003–1015 (2011)CrossRef S. Brauna, K. Bitton-Worms, D. le Roith, The link between the metabolic syndrome and cancer. Int. J. Biol. Sci. 7, 1003–1015 (2011)CrossRef
73.
Zurück zum Zitat N. Zhang, Q. Wang, Y. Tian, S. Xiong, G. Li, L. Xu, Expressions of IL-17 and TNF-α in patients with Hashimoto’s disease combined with thyroid cancer before and after surgery and their relationship with prognosis. Clin. Transl. Oncol. 22(8), 1280–1287 (2020)PubMedCrossRef N. Zhang, Q. Wang, Y. Tian, S. Xiong, G. Li, L. Xu, Expressions of IL-17 and TNF-α in patients with Hashimoto’s disease combined with thyroid cancer before and after surgery and their relationship with prognosis. Clin. Transl. Oncol. 22(8), 1280–1287 (2020)PubMedCrossRef
74.
Zurück zum Zitat J.K. Sethi, G.S. Hotamisligil, Metabolic messengers: tumour necrosis factor. Nat. Metab. 3, 1302–1312 (2021)PubMedCrossRef J.K. Sethi, G.S. Hotamisligil, Metabolic messengers: tumour necrosis factor. Nat. Metab. 3, 1302–1312 (2021)PubMedCrossRef
75.
Zurück zum Zitat X. Liu, L. Wang, H. Chi, J. Wang, Q. Zheng, J. Li et al. The SNP Rs915014 in MTHFR regulated by MiRNA associates with atherosclerosis. Cell. Physiol. Biochem. 45, 1149–1155 (2018)PubMedCrossRef X. Liu, L. Wang, H. Chi, J. Wang, Q. Zheng, J. Li et al. The SNP Rs915014 in MTHFR regulated by MiRNA associates with atherosclerosis. Cell. Physiol. Biochem. 45, 1149–1155 (2018)PubMedCrossRef
76.
Zurück zum Zitat K.N. Kim, Y. Hwang, K. Kim, K.E. Lee, Y.J. Park, J.Y. Choi et al. Active and passive smoking, BRAFV600E mutation status, and the risk of papillary thyroid cancer: a large-scale case-control and case-only study. Cancer Res. Treat.: Off. J. Korean Cancer Assoc. 51(4), 1392–1399 (2019)CrossRef K.N. Kim, Y. Hwang, K. Kim, K.E. Lee, Y.J. Park, J.Y. Choi et al. Active and passive smoking, BRAFV600E mutation status, and the risk of papillary thyroid cancer: a large-scale case-control and case-only study. Cancer Res. Treat.: Off. J. Korean Cancer Assoc. 51(4), 1392–1399 (2019)CrossRef
Metadaten
Titel
Geographic variation in the association between Hashimoto’s thyroiditis and Papillary thyroid carcinoma, a meta-analysis
verfasst von
Nabil W. G. Sweis
Ayman A. Zayed
Mira Al Jaberi
Lina AlQirem
Tala Basheer Hyasat
Farah A. Khraisat
Ward Maaita
Ahmad Moayad Naser
Abdullah Nimer
Mamoon Qatamin
Jaleel J. G. Sweis
Nadia Sweis
Abdallah T. Al-Ani
Ahmad M. Alghrabli
Alireza Haghighi
Publikationsdatum
02.05.2023
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 3/2023
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-023-03378-8

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Innere Medizin

Knochenmarktransplantat als Chance für ältere AML-Patienten

Lange Zeit ist die Transplantation von hämatopoetischen Stammzellen nur bei jüngeren Patienten mit akuter myeloischer Leukämie praktiziert worden. Inzwischen profitieren auch Ältere davon. Ergebnisse einer Studie unterstützen dieses Vorgehen.

Nierenzellkarzinom: Kein Nachteil durch subkutan appliziertes Nivolumab

Die subkutane Applikation von Nivolumab ist nach Daten einer Phase-3-Studie ähnlich gut wirksam wie die intravenöse: Die Pharmakokinetik ist vergleichbar, die objektive Response war in der Studie sogar leicht besser als in der Gruppe mit Infusionen.

Vorteile für Androgenentzug plus Androgenrezeptorblockade

Für Männer mit metastasiertem hormonsensitivem Prostata-Ca. (mHSPC), die keine Hormonchemotherapie wollen oder vertragen, ist der Androgenentzug plus Darolutamid eine Alternative: Das Progressionsrisiko wird im Vergleich zum alleinigen Androgenentzug fast halbiert.

Mit Lidocain kommt der Darm nicht schneller in Schwung

Verzögertes Wiederanspringen der Darmfunktion ist ein Hauptfaktor dafür, wenn Patientinnen und Patienten nach einer Kolonresektion länger als geplant im Krankenhaus bleiben müssen. Ob man diesem Problem mit Lidocain vorbeugen kann, war Thema einer Studie.

EKG Essentials: EKG befunden mit System (Link öffnet in neuem Fenster)

In diesem CME-Kurs können Sie Ihr Wissen zur EKG-Befundung anhand von zwölf Video-Tutorials auffrischen und 10 CME-Punkte sammeln.
Praxisnah, relevant und mit vielen Tipps & Tricks vom Profi.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.